DocSym
β
Searchsearch
Search
(T46.0) Poisoning: cardiac-stimulant glycosides and drugs of similar action
More details coming soon
264 130 in individuals diagnosis poisoning: cardiac-stimulant glycosides and drugs of similar action confirmed
Diagnosis poisoning: cardiac-stimulant glycosides and drugs of similar action is diagnosed Women are 12.26% more likely than Men
115 869
Men receive the diagnosis poisoning: cardiac-stimulant glycosides and drugs of similar action
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
148 261
Women receive the diagnosis poisoning: cardiac-stimulant glycosides and drugs of similar action
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease poisoning: cardiac-stimulant glycosides and drugs of similar action - Men and Women aged 0-5
In Men diagnosis is most often set at age 0-89, 95+
Less common in men the disease occurs at Age 90-94in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features poisoning: cardiac-stimulant glycosides and drugs of similar action
Absence or low individual and public risk
Poisoning: cardiac-stimulant glycosides and drugs of similar action - what does this mean
Cardiac-stimulant glycosides and drugs of similar action cause poisoning by increasing the heart rate, leading to arrhythmias, hypertension, and cardiac failure. these effects can be exacerbated by electrolyte imbalances, dehydration, and other underlying medical conditions.
What happens during the disease - poisoning: cardiac-stimulant glycosides and drugs of similar action
Poisoning with cardiac-stimulant glycosides and drugs of similar action results in an increase in the force of contraction of the heart, leading to increased heart rate and an increased workload on the heart. this can lead to a variety of symptoms, including arrhythmias, chest pain, shortness of breath, dizziness, and lightheadedness. in severe cases, it can lead to cardiac arrest and even death.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Liver function tests
- Electrolyte tests
- Chest X-ray
- ECG (electrocardiogram)
- Echocardiogram
- Cardiac stress test
- Toxicology screening
Treatment and Medical Assistance
The main goal of the treatment is to reduce the effects of poisoning from cardiac-stimulant glycosides and drugs of similar action.
- Administering activated charcoal
- Administering antidotes (such as atropine or pralidoxime)
- Providing supportive care (such as providing oxygen, monitoring vital signs, and administering intravenous fluids)
- Administering drugs to reduce the effects of the poison (such as beta-blockers or calcium channel blockers)
- Providing dialysis (for cases of severe poisoning)
7 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Poisoning: cardiac-stimulant glycosides and drugs of similar action - Prevention
The best way to prevent poisoning from cardiac-stimulant glycosides and drugs of similar action is to take them only as prescribed and to avoid taking them in combination with other medications. it is also important to store these drugs in a safe place and away from children, as accidental ingestion can be fatal.